论文部分内容阅读
2013对中国医药行业来说是一个多事之秋,医药行业的盈利模式不仅被各种舆论考验和质疑,而且这种盈利模式对整个社会的人性与道德也是一个极大的考验。在新一届领导人上台和各项政策趋于完善的社会背景下,许多关系到广大群众切身利益方面的矛盾都相继通过强大的网络及媒体曝光呈现在我们的面前。怎样才能在这样艰难的环境中突破原有的市场营销管理模式并取得新的市场机会呢?这就需要各大医药企业倾注全部精力到其中。本文主要从新市场环境下什么样的市场营销管理模式有利于企业发展方面进行论述。
2013 is a long-term event for the Chinese pharmaceutical industry. The pharmaceutical industry’s profit model is not only tested and questioned by various public opinions, but also a great test of the human nature and morality of the entire society. Under the social background in which the new leader has taken power and various policies have been perfected, many contradictions concerning the immediate interests of the broad masses of the people have emerged in front of us through a strong network and media exposure. How can we break through the original marketing management mode and gain new market opportunities in such a difficult environment? This requires that major pharmaceutical companies devote their full attention to them. This article mainly from the new market environment what kind of marketing management model is conducive to business development to be discussed.